Logo do repositório

Refractory pyoderma gangrenosum associated with rheumatoid arthritis successfully treated with upadacitinib. Comments on: “JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum”

dc.contributor.authordos Santos, Mayra Rabelo
dc.contributor.authorIanhez, Mayra
dc.contributor.authorRibeiro, Bruno Nazeozeno
dc.contributor.authorde Queiroz, Boaventura Braz
dc.contributor.authorMiot, Helio Amante [UNESP]
dc.contributor.institutionHospital de Doenças Tropicais Dr Anuar Auad
dc.contributor.institutionCentro Médico Alameda
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2025-04-29T20:06:07Z
dc.date.issued2023-11-01
dc.description.affiliationHospital de Doenças Tropicais Dr Anuar Auad, Goiás
dc.description.affiliationCentro Médico Alameda, Goiás
dc.description.affiliationUniversidade Estadual Paulista Júlio de Mesquita Filho, Campus de Botucatu, São Paulo
dc.description.affiliationUnespUniversidade Estadual Paulista Júlio de Mesquita Filho, Campus de Botucatu, São Paulo
dc.format.extente595-e598
dc.identifierhttp://dx.doi.org/10.1111/ijd.16791
dc.identifier.citationInternational Journal of Dermatology, v. 62, n. 11, p. e595-e598, 2023.
dc.identifier.doi10.1111/ijd.16791
dc.identifier.issn1365-4632
dc.identifier.issn0011-9059
dc.identifier.scopus2-s2.0-85164341128
dc.identifier.urihttps://hdl.handle.net/11449/306406
dc.language.isoeng
dc.relation.ispartofInternational Journal of Dermatology
dc.sourceScopus
dc.titleRefractory pyoderma gangrenosum associated with rheumatoid arthritis successfully treated with upadacitinib. Comments on: “JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum”en
dc.typeCartapt
dspace.entity.typePublication
unesp.author.orcid0000-0003-3604-3128[2]
unesp.author.orcid0000-0002-2596-9294[5]

Arquivos

Coleções